Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q4 2014 (Next →)
Filing Date: Feb 13, 2015
Total Value ($000): $147,603 (98.4% shares, 1.6% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 2,824,185 | $23,497 | 15.9% | $6.86 | 0.0% | Common | 03152W109 |
| — | TARO PHARMACEUTICAL INDUS | 83,800 | $12,418 | 8.4% | $148.19 | — | Shares | M8737E108 |
| — | RECEPTOS INC | 87,500 | $10,720 | 7.3% | $122.51 | — | Common | 756207106 |
| — | PERNIX THERAPEUTICS HOLDINGS | 1,134,578 | $10,654 | 7.2% | $9.39 | — | Common | 71426V108 |
| — | AGENUS - INC | 2,638,071 | $10,473 | 7.1% | $3.97 | — | Common | 00847G705 |
| SRNE | SORRENTO THERAPEUTICS INC | 910,100 | $9,165 | 6.2% | $5.07 | 0.0% | Common | 83587F202 |
| EBS | EMERGENT BIOSOLUTIONS INC | 330,635 | $9,003 | 6.1% | $23.83 | 0.0% | Common | 29089Q105 |
| — | MACROGENICS INC. | 162,500 | $5,699 | 3.9% | $35.07 | — | Common | 556099909 |
| — | ONCOTHYREON INC | 2,991,636 | $5,684 | 3.9% | $1.90 | — | Common | 682324108 |
| — | BELLICUM PHARMACEUTICALS INC | 220,000 | $5,069 | 3.4% | $23.04 | — | Common | 079481107 |
| — | LA JOLLA PHARMACEUTICAL CO. | 246,499 | $4,548 | 3.1% | $18.45 | — | Common | 503459604 |
| — | IGI LABORATORIES INC | 462,342 | $4,069 | 2.8% | $8.80 | — | Common | 449575109 |
| — | CELGENE CORP. | 150,000 | $3,924 | 2.7% | — | — | Call | 151020104 |
| — | ARROWHEAD RESEARCH - CORP | 525,000 | $3,875 | 2.6% | $7.38 | — | Common | 042797209 |
| — | FLAMEL TECHNOLOGIES | 214,805 | $3,680 | 2.5% | $17.13 | — | Sponsored ADR | 338488109 |
| — | IGNYTA INC. | 521,233 | $3,570 | 2.4% | $6.85 | — | Common | 451731103 |
| — | ALIMERA SCIENCES INC | 674,593 | $3,389 | 2.3% | $5.02 | — | Common | 016259103 |
| — | DYNAVAX TECHNOLOGIES CORP | 199,332 | $3,361 | 2.3% | $16.86 | — | Common | 268158201 |
| VCEL | VERICEL CORP. | 1,058,820 | $3,219 | 2.2% | $2.85 | 0.0% | Common | 92346J108 |
| — | EXELIXIS INC EXEL 20190815 4.250000% | 4,250,000 | $2,398 | 1.6% | $0.56 | — | Notes | 30161QAC8 |
| — | BIOLASE INC | 784,500 | $2,063 | 1.4% | $2.63 | — | Common | 090911108 |
| — | NOVAVAX INC | 300,000 | $1,779 | 1.2% | $5.93 | — | Common | 670002104 |
| CPRX | CATALYST PHARMACEUTICAL PART.. | 550,670 | $1,635 | 1.1% | $2.74 | 0.0% | Common | 14888U101 |
| — | INNOCOLL AG | 225,000 | $1,335 | 0.9% | $5.93 | — | Sponsored ADR | 45780Q103 |
| — | FORWARD PHARMA A/S-ADR | 50,000 | $1,042 | 0.7% | $20.84 | — | Sponsored ADR | 34986J105 |
| HRTX | HERON THERAPEUTICS INC | 65,900 | $663 | 0.4% | $8.16 | 0.0% | Common | 427746102 |
| — | BIOTA PHARMACEUTICALS- INC | 258,586 | $579 | 0.4% | $2.24 | — | Common | 090694100 |
| — | RECEPTOS INC | 20,000 | $82 | 0.1% | $122.51 | — | Put | 756207106 |
| — | CUBIST PHARMA-RTS | 141,688 | $6 | 0.0% | $0.04 | — | Rights | 229678123 |
| EXAS | EXACT SCIENCES CORP. | 9,600 | $4 | 0.0% | — | — | Put | 30063P105 |